Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Divi's Laboratories Ltd.
NSE: DIVISLAB
|
BSE: 532488
|
ISIN: INE361B01024
|
Industry: Pharmaceuticals
|
Expensive Performer
6013.0000
-127.00
(
-2.07
%)
NSE
Jan 20, 2026
15:31 PM
Volume:
204.4K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Divi's Laboratories Ltd.
22 May 2023
6013.00
-2.07%
Healthy pick-up in API sales drives earnings
Neutral:
Divi's Laboratories Ltd.
by
Motilal Oswal
Target: 2900
Target
Motilal Oswal
Divi's Laboratories .. has an
average target
of 6270.00 from 6 brokers.
More from Divi's Laboratories Ltd.
Recommended
Five stocks to buy from analysts this week - January 20, 2026
The Baseline |
20 Jan 2026, 05:30PM
Market closes lower, amid foreign fund outflows & global trade uncertainty
Trendlyne Marketwatch |
20 Jan 2026, 04:03PM
Custom synthesis business drives growth for Divi’s Laboratories
|
10 Mar 2022